Filgotinib Maleate is an oral anti-inflammatory agent classified as a selective Janus kinase (JAK) 1 inhibitor. It is utilized in the management of autoimmune and inflammatory conditions, including rheumatoid… Read more
Filgotinib Maleate is an oral anti-inflammatory agent classified as a selective Janus kinase (JAK) 1 inhibitor. It is utilized in the management of autoimmune and inflammatory conditions, including rheumatoid arthritis, ulcerative colitis, and Crohn's disease, by modulating cytokine signaling pathways to reduce inflammatory responses. Pharmaceutical laboratories rely on a comprehensive range of high-quality reference standards, including the active ingredient itself, to support rigorous analytical testing. This category contains essential related compounds such as known process-related impurities, degradation products, and metabolites, which are critical for accurate impurity profiling and method validation. Furthermore, the inclusion of stable isotope labelled compounds provides the necessary precision for quantitative analysis and the assessment of metabolic pathways during drug development and quality control processes. These tools ensure that analytical procedures consistently meet regulatory specifications for product safety and efficacy.